High expression of SIRT3 is associated with an unfavorable clinical prognosis of diseases such as esophageal cancer, colon cancer, stomach cancer [115,116,117], third degree breast cancer [118], oral squamous cell carcinoma [119], melanoma [120], kidney cancer [121], and thyroid cancer [122]. Here, SIRT3 is linked to breast cancer.